search
Back to results

Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and Insulin (L-Arabinose)

Primary Purpose

Pre-diabetes

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
L-Arabinose and Chromium
Sucrose without dietary Supplement
Sponsored by
Integrative Health Technologies, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Pre-diabetes focused on measuring glucose, insulin, L-arabinose, Chromium

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • All study subjects were required to contact their family physician to ensure they had no medical conditions that would preclude their participation.

Exclusion Criteria:

  • Diabetics, and
  • Those not approved by their physicians.

Sites / Locations

  • Integrative Health Technologies

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Sucrose with Dietary Supplement

Sucrose without Dietary Supplement

Arm Description

Repeated measures on subjects taking 70 grams of sucrose along with taking a dietary supplement containing L-Arabinose and Chromium

Consumed 70 grams of sucrose without simultaneously taking the dietary supplement

Outcomes

Primary Outcome Measures

Fasting Blood Glucose
Finger-stick glucose measurements taken every 15 or 30 minutes after taking a 70 gram sucrose challenge with and without the dietary supplement

Secondary Outcome Measures

Fasting Blood Insulin Levels
A venipuncture blood test taken 30, 60, 90 and 120 minutes after taking a 70 gram sucrose challenge with and without taking the dietary supplement

Full Information

First Posted
April 19, 2010
Last Updated
May 11, 2011
Sponsor
Integrative Health Technologies, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT01107431
Brief Title
Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and Insulin
Acronym
L-Arabinose
Official Title
A Combination of L-Arabinose and Chromium Lowers Circulating Glucose and Insulin Levels After Acute Oral Sucrose Challenge
Study Type
Interventional

2. Study Status

Record Verification Date
May 2011
Overall Recruitment Status
Completed
Study Start Date
December 2008 (undefined)
Primary Completion Date
December 2009 (Actual)
Study Completion Date
December 2009 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Integrative Health Technologies, Inc.

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study was designed to examine changes in capillary blood glucose and venous insulin levels after a 70 gram oral sucrose challenge with and without simultaneous consumption of a dietary supplement containing L-Arabinose and a patented version of chromium (LA-Cr).
Detailed Description
This study concluded that consumption of the LA-Cr supplement in conjunction with a 70-gram sucrose challenge led to a significant reduction of capillary blood glucose and venous insulin as compared to the sucrose challenge without the LA-Cr supplement. This finding may provide an important tool to reduce the adverse effects associated with elevated glucose and insulin levels.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pre-diabetes
Keywords
glucose, insulin, L-arabinose, Chromium

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
70 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Sucrose with Dietary Supplement
Arm Type
Active Comparator
Arm Description
Repeated measures on subjects taking 70 grams of sucrose along with taking a dietary supplement containing L-Arabinose and Chromium
Arm Title
Sucrose without Dietary Supplement
Arm Type
Active Comparator
Arm Description
Consumed 70 grams of sucrose without simultaneously taking the dietary supplement
Intervention Type
Dietary Supplement
Intervention Name(s)
L-Arabinose and Chromium
Other Intervention Name(s)
70 grams of cane sugar along with supplement
Intervention Description
Consumed 70 grams of sucrose simultaneously taking a dietary supplement
Intervention Type
Dietary Supplement
Intervention Name(s)
Sucrose without dietary Supplement
Other Intervention Name(s)
70 grams of cane sugar with supplement
Intervention Description
Repeated measures on subjects taking 70 grams of sucrose along with taking a dietary supplement containing L-Arabinose and Chromium
Primary Outcome Measure Information:
Title
Fasting Blood Glucose
Description
Finger-stick glucose measurements taken every 15 or 30 minutes after taking a 70 gram sucrose challenge with and without the dietary supplement
Time Frame
Every 15 to 30 minutes
Secondary Outcome Measure Information:
Title
Fasting Blood Insulin Levels
Description
A venipuncture blood test taken 30, 60, 90 and 120 minutes after taking a 70 gram sucrose challenge with and without taking the dietary supplement
Time Frame
Every 30 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: All study subjects were required to contact their family physician to ensure they had no medical conditions that would preclude their participation. Exclusion Criteria: Diabetics, and Those not approved by their physicians.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gilbert R Kaats, PhD
Organizational Affiliation
Integrative Health Technologies
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Harry G Preuss, MD
Organizational Affiliation
Georgetown University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Integrative Health Technologies
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78209
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
21548959
Citation
Kaats GR, Keith SC, Keith PL, Leckie RB, Perricone NV, Preuss HG. A combination of l-arabinose and chromium lowers circulating glucose and insulin levels after an acute oral sucrose challenge. Nutr J. 2011 May 6;10:42. doi: 10.1186/1475-2891-10-42.
Results Reference
derived

Learn more about this trial

Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and Insulin

We'll reach out to this number within 24 hrs